A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants

A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: Impact of BRCA pathogenic variants

Abstract Background Better tools for post‐chemotherapy amenorrhea risk assessment are needed for fertility preservation decision‐making. Our aim was to determine the predictors of amenorrhea risk at 12 and 18 months post‐chemotherapy in women with breast cancer. Methods 142 women with breast cancer...

Full description

Bibliographic Details
Main Authors: Kutluk H. Oktay, Volkan Turan, Giuliano Bedoschi, Nadia Abdo, Heejung Bang, Shari Goldfarb
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
amenorrhea
anti‐mullerian hormone
BRCA
breast cancer
chemotherapy
fertility preservation
Online Access:https://doi.org/10.1002/cam4.6527

Internet

https://doi.org/10.1002/cam4.6527

Similar Items